SCHEMBL17448124

SCHEMBL17448124

CCCC(=O)c1ccc(NC(c2c(C)n[nH]c2C)C(C)(C)C)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.38
HSD17B3 P37058 7/20 0.38
FRK P42685 1/20 0.37
CAMK2B Q13554 1/20 0.37
CAMK2G Q13555 1/20 0.37
CAMK2D Q13557 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
AR P10275 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
LMNA P02545 2/20 0.33
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
ATM Q13315 1/20 0.32
STS P08842 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC1 Q13547 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4918277 0.85 HSD17B3 (0.40) CYP2C19HSD17B3FRKCAMK2BCAMK2G
SCHEMBL4913283 0.80 HPGD (0.42) CYP2C19HSD17B3L3MBTL1HPGDSMN1; SMN2
SCHEMBL3639107 0.72 FRK (0.47) CYP2C19HSD17B3FRKCAMK2BCAMK2G
SCHEMBL4917945 0.72 SMN1; SMN2 (0.40) CYP2C19HSD17B3L3MBTL1HPGDSMN1; SMN2
SCHEMBL4915288 0.71 HSD17B3 (0.40) CYP2C19HSD17B3FRKCAMK2BCAMK2G
SCHEMBL4913661 0.69 MMP1 (0.40) CYP2C19L3MBTL1HPGDSMN1; SMN2MEN1
SCHEMBL18748246 0.68 HSD17B3 (0.56) HSD17B3L3MBTL1HPGDSMN1; SMN2THRA
SCHEMBL4922084 0.68 HSD17B3 (0.40) CYP2C19HSD17B3FRKCAMK2BCAMK2G
SCHEMBL4911780 0.68 HSD17B3 (0.40) CYP2C19HSD17B3FRKCAMK2BCAMK2G
SCHEMBL4913265 0.68 FRK (0.43) HSD17B3FRKCAMK2BCAMK2GCAMK2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9242933-B2 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor) AbbVie Deutschland GmbH & Co. KG (DE) 2016-01-26 US claimed